Design and Optimization of Manufacturing

Process Scale Purification of Antibodies

Volumn , Issue , 2008, Pages 263-291

  Sinclair, Andrew ^a  

^a BioPharm Services UK   (United Kingdom)

Author keywords

Cost models in practice; Design and optimization of manufacturing; Simulation in practice

Indexed keywords

EID: 84890699028     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470444894.ch13     Document Type: Chapter

References (16)

1. Elmasry, H. (2004). Capital Intensity and Stock Returns. Morgan Stanley Investment Management. Available at http://www.morganstanley.com/im/resources/mkinsights/pdfs/gl_fran.pdf, accessed November 2007.
2. US Department of Commerce (2003). A Survey of the Use of Biotechnology in US Industry. US Department of Commerce Technology Administration Bureau of Industry and Security. Available at http://www.scribd.com/doc/2409900/A-survey - of-the-use-of-biotechnology-in-U-S-industry-2006, accessed November 2007.
3. Tufts Center for the Study of Drug Development (2005). Outlook 2005. Available at http://www.pharmamanufacturing.com, accessed November 2007.
4. Tufts Center for the Study of Drug Development (2007). Outlook 2007. Available at http://www.pharmamanufacturing.com, accessed November 2007.
5. Pavlou, A., Reichert, J. (2004). Recombinant protein therapeutics - Success rates, market trends and values to 2010. Nature Biotechnology 22, 1513-1519.
6. Hill, C., Sinclair, A. (2007). Process development: Maximizing process data from development to manufacturing. BioPharm International 20, 38-43.
7. American National Standards Institute/Instrumentation, Systems, and Automation Society (ANSI/ISA) (1995). ANSI/ISA-88.01-1995 Batch Control Part 1: Models and Terminology. The Instrumentation, Systems, and Automation Society, Research Triangle Park, NC.
8. American National Standards Institute/Instrumentation, Systems, and Automation Society (ANSI/ISA) (2003). ANSI/ISA-88.00.03-2003 Batch Control Part 3: General and Site Recipe Models and Representation. The Instrumentation, Systems, and Automation Society, Research Triangle Park, NC.
9. Remer, D.S., Idrove, H.J. (1991). Cost estimating factors for biopharmaceutical process equipment. Pharmaceutical Technology International 3, 36-42.
10. Rouf, S.A., Douglas, P.L., Moo-Young, M., Scharer, J.M. (2001). Computer simulation for large scale bioprocess design. Biochemical Engineering Journal 8, 229-234.
11. Shanklin, T., Roper, K., Yegneswaran, P.K., Marten, M.R. (2001). Selection of bioprocess simulation software for industrial applications. Biotechnology and Bioengineering 72, 483-489.
12. Adamson, R. (2006). A new era in biotechnology. Presentation at the Disposables For Biopharmaceutical Manufacturing Meeting, Dublin, ROI, 2006.
13. Hodge, G. (2004). Disposable components enable a new approach to biopharmaceutical manufacturing. BioPharm International 17, 38-49.
14. Sinclair, A., Monge, M. (2004). Biomanufacturing for the 21st century. Designing a concept facility based on single-use systems. BioProcess International 2, 26-31.
15. Sinclair, A., Monge, M. (2005). Concept facility based on single-use systems, part 2 - Leading the way for biomanufacturing in the 21st century. BioProcess International 3, 51-55.
16. Lim, J.A.C., Sinclair, A., Kim, D.S., Gottschalk, U. (2007). Economic benefits of single-use membrane chromatography in polishing - A cost of goods model. Bio- Process International 5, 48-56.